# Post-Market Study of the Argus® II Retinal Prosthesis System - France

> **NCT02303288** · — · COMPLETED · sponsor: **Second Sight Medical Products** · enrollment: 18 (actual)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DEVICE:** Argus II Retinal Prosthesis System

## Key facts

- **NCT ID:** NCT02303288
- **Lead sponsor:** Second Sight Medical Products
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-20
- **Primary completion:** 2018-03-20
- **Final completion:** 2018-11-20
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02303288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02303288, "Post-Market Study of the Argus® II Retinal Prosthesis System - France". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02303288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*